Webull Biotech Sector Webinar
investorperriman
CCO of eXoZymes, Perriman, to present at Webull's 'Biotech Sector' webinarJune 18, 2026
$6M fundraise closed
press releaseinvestor
eXoZymes Inc. Announces Closing of $6 Million Public OfferingJune 17, 2026
EXOZ announces pricing of public offering
press releaseinvestor
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and WarrantsJune 8, 2026
Rolling Stone: Next-gen cannabinoids - the innovative race to manufacture compounds
investormedicinepress clippingscannabinoids
Rolling Stone: Next-gen cannabinoids - the innovative race to manufacture compoundsMay 15, 2026
Finding Genius: eXoZymes AI-Enhanced Enzymes & The Future Of Sustainable Manufacturing
press clippingssciencepodcastNCTcannabinoidskorman
Finding Genius podcast: AI enhanced enzymes & the future of sustainable manufacturingMay 12, 2026
EXOZ investor presentation by Chris Marlett
investorvideo
Updated EXOZ investor presentation by Chris MarlettMay 11, 2026
GCxN x EXOZ
biofuelpress releasekorman
eXoZymes Announces Graduation from Shell GameChanger™ Accelerator Powered by NLR (GCxN) ProgramMay 7, 2026
WTR Healthcare Happenings
heltzennutraceuticalspress clippingspodcastNCT
WTR podcast: Unlocking Hard-to-Scale Molecules with AI-Driven, Cell-Free BiomanufacturingMay 6, 2026
Podcast: CEO Heltzen @ Executive Insights for Life Sciences Innovators
heltzenpress clippingsvideopodcast
Podcast: CEO Heltzen @ Executive Insights for Life Sciences InnovatorsApril 20, 2026
Damien Perriman interviewed for Springwise
press clippingsperrimanNCT
Springwise case study: Unpacking how eXoZymes and Cayman Chemical are rethinking chemical manufacturingApril 17, 2026
Previous page
Page 1 of 13
Next page